Partnerships
International Perinatal Research (INPRES) Partnership
The INPRES Partnership is a collaboration between institutions around the world, leading and undertaking research in the field of perinatology.
The Partnership, founded in 2021 by two world-leading paediatric clinical trials unit: Melbourne Children's Trial Centre (MCTC) and the University of Oxford's National Perinatal Epidemiology Unit (NPEU) Clinical Trials Unit, aims to support clinicians and researchers in developing and facilitating clinical trials and observational research projects in the perinatal, neonatal, and paediatric population.
The goal of INPRES is to enable the world's experts in the perinatal, neonatal, and paediatric clinical research field to work together to improve diagnosis, implement personalised treatment decisions, and develop new treatment strategies that will benefit newborn infants and their families around the world.
The cross-border sharing of expertise, knowledge and leveraging of scientific and clinical strengths between leading perinatal clinician scientists and clinical trial teams, will accelerate and advance the development and execution of collaborative, international, investigator-led research.
Through the Partnership, collaborations are facilitated to promote and foster clinical research, combining research efforts already underway in addition to developing new research proposals. This involves cooperation at multiple levels including the individual project level, as well as partnering to develop the infrastructure required to support programs of research.
All members will work together to lay the groundwork for future networking prospects, with the intent of expanding to include additional perinatal, neonatal, and paediatric research groups globally, in order to further accomplish its mission.
Current Partners